Michael Okunewitch

Stock Analyst at Maxim Group

(1.46)
# 3,514
Out of 5,033 analysts
29
Total ratings
28%
Success rate
-0.53%
Average return

Stocks Rated by Michael Okunewitch

Rani Therapeutics Holdings
Oct 20, 2025
Maintains: Buy
Price Target: $5$10
Current: $3.03
Upside: +230.03%
Citius Oncology
Sep 23, 2025
Upgrades: Buy
Price Target: $6
Current: $1.75
Upside: +242.74%
Anebulo Pharmaceuticals
Jul 23, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.77
Upside: -
HCW Biologics
May 29, 2025
Maintains: Buy
Price Target: $120$35
Current: $3.96
Upside: +783.84%
Radiopharm Theranostics
May 1, 2025
Initiates: Buy
Price Target: $12
Current: $6.13
Upside: +95.92%
Chemomab Therapeutics
Feb 20, 2025
Maintains: Buy
Price Target: $16$28
Current: $3.42
Upside: +718.71%
Mainz Biomed
Feb 14, 2025
Initiates: Buy
Price Target: $14
Current: $1.55
Upside: +803.23%
Lineage Cell Therapeutics
Jan 10, 2025
Maintains: Buy
Price Target: $5$3
Current: $1.66
Upside: +80.72%
Ocugen
Oct 15, 2024
Initiates: Buy
Price Target: $4
Current: $1.56
Upside: +157.23%
FibroBiologics
Sep 24, 2024
Initiates: Buy
Price Target: $12
Current: $0.41
Upside: +2,806.98%
Maintains: Buy
Price Target: $15$6
Current: $0.83
Upside: +627.27%
Maintains: Buy
Price Target: $3$12
Current: $0.92
Upside: +1,197.44%
Initiates: Buy
Price Target: $24
Current: $1.94
Upside: +1,137.11%
Maintains: Buy
Price Target: $108$18
Current: $2.62
Upside: +587.02%
Initiates: Buy
Price Target: $2,025
Current: $2.37
Upside: +85,343.04%
Initiates: Buy
Price Target: $25
Current: $18.98
Upside: +31.72%
Initiates: Buy
Price Target: $6
Current: $1.60
Upside: +275.00%
Initiates: Buy
Price Target: $25
Current: $6.05
Upside: +313.56%
Initiates: Buy
Price Target: $100
Current: $1.68
Upside: +5,852.38%